Subbiah V, Curigliano G, Sicklick JK, Kato S, Tasken K, Medford A, Rieke DT, Chen HZ, Wahida A, Buschhorn L, Horgan D, Kurzrock R(2025) Cancer treatment paradigms in the precision medicine era Nat Med(in press) DOI 10.1038/s41591-025-03711-w, PubMed 40394190
Yin Y, Xu H, He L, Brown JR, Mato AR, Aittokallio T, Skånland SS(2025) Protein Profiles Predict Treatment Responses to the PI3K Inhibitor Umbralisib in Patients with Chronic Lymphocytic Leukemia Clin Cancer Res, 31(10), 1943-1955 DOI 10.1158/1078-0432.CCR-24-2911, PubMed 40085050
Taskén K, Mahon P(2025) Accelerating precision oncology by converging pragmatic trials and real-world evidence Nat Rev Drug Discov(in press) DOI 10.1038/d41573-025-00047-5, PubMed 40082591